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ABSTRACT 
Objectives: To investigate the rate of neural tube defects bifida was 0.88 per 1000. We found that 32% of mothers 
(NTDs) and their relation to gender, maternal age, with affected newborns had taken drugs during the first 
consanguineous marriage, season, and drug consumption trimester of pregnancy, 90% of mothers did not consume 
in Birjand, Iran. folate before and during the first trimester, and 54% of 
parents had consanguineous marriage.Methods: This research was carried out on 16,785 live 
or stillborn newborns in Birjand, Iran from April 1997 to Conclusion: We concluded that folate deficiency, usage December 2001. 
of drugs during pregnancy, and consanguineous marriage 
Results: The rate of NTDs was 2.97 per 1000. This rate may play a role of predisposition to NTD. 
was 1.97 per 1000 in males, and 3.55 per 1000 in females. 
The rate of anencephaly was 1.37 per 1000, and spina Neurosciences 2006; Vol. 11 (4): 289-292 
Neural tube defects (NTDs) result in congenital malformations of the nervous system and may 
lead to spontaneous abortion, stillbirth, or death in 
early infancy, or a lifetime of disability.1 Neural tube 
defects, the most common of which are anencephaly, 
spina bifida, and encephalocele, result from 
multifactorial disturbances in embryonic neurulation.2 
Numerous risk factors have been identified for NTDs. 
Exposure to methotrexate, valproic acid, aminopterin, 
maternal diabetes, hyperthermia, low socioeconomic 
status, and lack of folate have been shown to increase 
the risk of NTDs.1,3-11 Also, genetic risk factors are 
believed to be important.12 The prevalence of NTD 
at birth varies considerably by country, geographic 
zones, ethnic and racial groups, and ranges from 
as high as 1 case in 100 births in some regions of 
China, to approximately 1 case in 5000 or less in 
some Scandinavian countries. In many countries, the 
prevalence is approximately 1 in 1000 births.10 We 
carried out this study in Birjand, in the south-east of 
the Khorasan province, Iran (Afghanistan border), to 
ascertain a relationship between the NTDs and the 
following factors; sex, maternal age, consanguineous 
marriage, season, drugs consumption, history of 
disease, and also to investigate the rate of NTDs. 
Methods.This descriptive and cross-sectional study 
was carried out on 16,785 live or stillborn newborns 
from April 1997 to December 2001 in 2 hospitals 
(Imam Reza and Mehr) in Birjand, South East Iran. 
Cases were defined as women residing in Birjand who 
delivered live or stillborn newborns with neural tube 
defects (ICD-9). Demographic characteristics of the 
neonates and their parents such as sex, date of birth, 
type of NTD, mother’s age, consanguineous marriage, 
drug consumption, mother’s diseases, and history of 
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Table 1 - The rate of type of NTDs per 1000 birth. 
NTDs No. (%)  Rate per
1000 
Anencephaly 23  (46) 1.37 
Spina bifida 8  (16) 0.47 
Spina bifida & hydrocephalus 7  (14) 0.41 
NTD & other anomalies 6  (12) 0.36 
Encephalocele 3  (6) 0.18 
Iniencephaly 3  (6) 0.18 
Total 50 (100) 2.97 
NTDs - Neural tube defects 
malformed newborn, were recorded in the medical 
chart. All NTDs rates were calculated per 1000 births. 
The data were analyzed by SPSS, Version 10. Chi-
square, fisher exact and student’s t-test was applied 
whenever necessary. The p-value of a=0.05 or less 
was considered statistically significant. 
Results. During 1997-2001, there were 16,785 
births in 2 hospitals. Among this sample population, 
there were 8609 males, 8154 females and 22 ambiguous
genitalia. During the period under consideration, we 
found 50 live and stillborn newborns with NTDs. 
These were made up of 29 females, 17 males and 4 
newborns with ambiguous genitalia. The rate of NTDs 
was 2.97 per 1000 births. The rate of NTDs was 1.97 
per 100 for males and 3.55 per 1000 for females. The 
female/male ratio of NTDs was 1.71. This difference 
was not statistically significant. The distribution of 
type of NTDs is depicted in Table 1. In this study, the 
rate of anencephaly in the total population was 1.37, 
and spina bifida was 0.88 per 1000. The mean age 
of mothers was 28±6 and of fathers was 32±9 years. 
Twenty-seven (54%) of the 50 offspring were derived 
from consanguineous marriage and the parents were 
not related in the other 46% (Table 2). Thirty-two 
percent of the newborns with NTDs were born in 
winter. In spring, 26% were born, 14% in summer, and 
28% of affected newborns were born autumn. In this 
study, 32% of mothers with malformed newborns had 
taken drugs during the first trimester of pregnancy, 
and 46% of them had disease during pregnancy (Table 
2). In addition, 90% of mothers’ with NTD newborns 
did not consume folate before and during the first 
trimester of pregnancy. 
Discussion. Our results indicate that the rate 
of NTDs was 2.97 per 1000, which is higher than 
other studies from Canada at 1.41/10000,13 South 
 Table 2 - Distribution of consanguineous marriage, type of delivery, disease and drug consumption in mothers with affected newborn according to 
type of NTDs. 
Spina Spina bifida & NTD & NTDS Anencephaly Encephalocele Iniencephaly Total bifida Hydrocephalus other anomalies Risk factors N=23 N=3 N=3 N=50 N=8 N=7 N=6 
No. (%) 
Consanguineous marriage 
No 11 (47.8) 4 (17.4) 2 (8.7) 2 (8.7) 2 (8.7) 2 (8.7) 23 
Yes - type 3,4 8 (40) 4 (20) 1 (5) 1 (5) 4 (20) 2 (10) 20 
- type 5,6 4 (57.1) 0 (0) 0 (0) 0 (0) 1 (14.3) 2 (28.6) 7 
Type of delivery 
Vaginal 19 (59.4) 4 (12.5) 2 (6.3) 0 (0) 2 (6.3) 5 (15.6) 32 
Cesarean section 4 (22.2) 4 (22.2) 1 (5.6) 3 (16.7) 5 (27.8) 1 (5.6) 18 
Disease during pregnancy 
No 15 (55.6) 4 (14.8) 1 (3.7) 1 (3.7) 3 (11.1) 3 (11.1) 27 
Yes - FUO 1 (14.3)
 - diabetes mellitus 0 (0)
 - other 7 (53.8) 
2 (28.6)
1 (33.3)
1 (7.7) 
1 (14.3)
0 (0)
1 (7.7) 
0 (0)
0 (0)
2 (15.4) 
2 (28.6)
1 (33.3)
1 (7.7) 
1 (14.3)
1 (33.3)
1 (7.7) 
7 
3 
13 
Drug consumption during pregnancy 
No 16 (47.1) 5 (14.7) 2 (5.9) 2 (5.9) 4 (11.8) 5 (14.7) 34 
Yes - analgesic
- antibiotic
 - other 
4 (66.7)
1 (20)
2 (40) 
0 (0)
2 (40)
1 (20) 
1 (16.7)
0 (0)
0 (0) 
0 (0)
0 (0)
1 (20) 
1 (16.7)
1 (20)
1 (20) 
0 (0)
1 (20)
0 (0) 
6 
5 
5 
NTD - neural tube defect, FUO - fever of unknown origin 
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Africa 1.7/1000,14 Portugal 0.6/10000,15 Germany
1.5/1000,16 the north of England 17.9/10.000,17 the 
north of France 10.94/10000,18 and the USA 9.3-
14.6/10000.19 However, this rate is lower than China 
with 6/1000,20 Turkey with 30.1/10000,21 south-east 
of the Caspian Sea with 3.12/1000,22 and north-
east Iran with 50.1/10000.23 Regarding gender, our 
results indicated that the rate of NTDs is higher in 
females than males, similar to rates reported by other 
researchers.19,23-27 Among the NTD malformations, 
anencephaly was the most common, which was not 
similar in comparison with other studies.2,28 Some 
reports have shown that spina-bifida is the most 
common form of NTD. The higher rates of NTDs 
we found when the conception took place in winter 
is in accordance with other investigations.22,23 Some 
research has shown that parental consanguineous 
marriage is higher in NTDs.28,29 In this study, 54% 
of parents had consanguineous marriages. Other 
investigations have shown that age is a complex risk 
factor in NTDs.30,31 In some malformations, the rate 
of malformations is higher with increasing maternal 
age, but in NTDs, there is no linear relation between 
the high rate of NTDs and increasing maternal age. 
Meaning that mothers with age <18 and age >35, 
both have a high chance of newborns with NTDs.32-34 
In this study, 90% of mothers with NTD newborns 
did not consume folate before and during the first 
trimester of pregnancy. In recent years, extensive 
investigation has shown that folate has a preventive 
effect on NTDs.30,35-38 
Concerning the high rate of NTDs in this region 
and due to multifactorial causes of NTDs, we 
conclude that folate deficiency, usage of drugs during 
pregnancy, and consanguineous marriage may play 
a role in predisposition to NTD. Therefore, further 
studies are essential. 
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